A The four-year project brings together
It has been awarded funding from the
More than 250,000 patients across
Haemodialysis, the most common treatment, sees blood taken from a vascular access site in the arm, passed through a dialysis machine and returned to the patient three times a week. The problem is vascular access sites fail in at least half of patients in the first year, leading to infections, hospital stays and operations.
The ReDVA - Development of hemodynamic solutions in Renal Dialysis Venous Access - consortium will examine the problems that occur during long-term haemodialysis.
Lead researcher Professor
The four-year project brings together